Related Experiment Video
Updated: Sep 13, 2025

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology
Fedor Levin1, Martin Dyrba2, Stefan J Teipel2,3
1Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Rostock, Germany. fedor.levin@dzne.de.
Background:
Neuroimaging studies have identified distinct 'typical/neocortical' and 'limbic-predominant' hypometabolic subtypes of AD with different clinical and biomarker characteristics. We investigated associations of these subtypes with postmortem neuropathological measures in an observational study.
Methods:
Antemortem FDG-PET scans of 74 participants from the ADNI autopsy cohort were classified into previously described typical/neocortical and limbic-predominant subtype patterns. We used Bayesian regression and ANCOVA to test associations between the subtypes and neuropathological features.
Results:
Results were inconclusive for Thal phases, Braak stages, CERAD neuritic plaque scores, hippocampal tangle density, and TDP-43 pathology (BF10 between 0.447 and 1.146). However, the limbic-predominant subtype was associated with hippocampal sclerosis (BF10 = 3.842, moderate level of evidence), whereas the typical/neocortical subtype was associated with Lewy body pathology (BF10 = 10.093, strong level of evidence).
Conclusions:
These findings highlight the influence of AD and non-AD-specific pathologies on neurodegeneration patterns and may provide directions for research into hypometabolic pattern analysis as an indirect marker of comorbid pathology.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

